JP2007097598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007097598A5 JP2007097598A5 JP2007000148A JP2007000148A JP2007097598A5 JP 2007097598 A5 JP2007097598 A5 JP 2007097598A5 JP 2007000148 A JP2007000148 A JP 2007000148A JP 2007000148 A JP2007000148 A JP 2007000148A JP 2007097598 A5 JP2007097598 A5 JP 2007097598A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- ser
- acid sequence
- variable domain
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0001448.0A GB0001448D0 (en) | 2000-01-21 | 2000-01-21 | Organic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001553825A Division JP3978338B2 (ja) | 2000-01-21 | 2001-01-19 | ヒトＩＬ−１βに対する抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007097598A JP2007097598A (ja) | 2007-04-19 |
| JP2007097598A5 true JP2007097598A5 (https=) | 2007-11-15 |
Family
ID=9884137
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001553825A Expired - Fee Related JP3978338B2 (ja) | 2000-01-21 | 2001-01-19 | ヒトＩＬ−１βに対する抗体 |
| JP2007000148A Pending JP2007097598A (ja) | 2000-01-21 | 2007-01-04 | ヒトＩＬ−１βに対する抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001553825A Expired - Fee Related JP3978338B2 (ja) | 2000-01-21 | 2001-01-19 | ヒトＩＬ−１βに対する抗体 |
Country Status (33)
| Country | Link |
|---|---|
| US (4) | US20030124617A1 (https=) |
| EP (1) | EP1248804B2 (https=) |
| JP (2) | JP3978338B2 (https=) |
| KR (1) | KR100697126B1 (https=) |
| CN (1) | CN1395581B (https=) |
| AR (1) | AR027253A1 (https=) |
| AT (1) | ATE346868T1 (https=) |
| AU (1) | AU772949B2 (https=) |
| BR (1) | BR0107661A (https=) |
| CA (1) | CA2396212C (https=) |
| CO (1) | CO5261584A1 (https=) |
| CY (1) | CY1107989T1 (https=) |
| CZ (1) | CZ302738B6 (https=) |
| DE (1) | DE60124863T3 (https=) |
| DK (1) | DK1248804T4 (https=) |
| ES (1) | ES2274865T5 (https=) |
| GB (1) | GB0001448D0 (https=) |
| HK (1) | HK1050013A1 (https=) |
| HU (1) | HUP0204156A3 (https=) |
| IL (2) | IL150551A0 (https=) |
| MX (1) | MXPA02007091A (https=) |
| MY (1) | MY155269A (https=) |
| NO (1) | NO329816B1 (https=) |
| NZ (1) | NZ519936A (https=) |
| PE (1) | PE20011219A1 (https=) |
| PL (1) | PL207642B1 (https=) |
| PT (1) | PT1248804E (https=) |
| RU (1) | RU2264413C2 (https=) |
| SI (1) | SI1248804T2 (https=) |
| SK (1) | SK288054B6 (https=) |
| TR (1) | TR200201780T2 (https=) |
| WO (1) | WO2001053353A2 (https=) |
| ZA (1) | ZA200205659B (https=) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0001448D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
| KR100919593B1 (ko) | 2000-06-29 | 2009-09-29 | 아보트 러보러터리즈 | 이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물 |
| GB0020685D0 (en) | 2000-08-22 | 2000-10-11 | Novartis Ag | Organic compounds |
| CA2474616A1 (en) * | 2002-01-28 | 2003-08-07 | Medarex, Inc. | Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| GB0303337D0 (en) | 2003-02-13 | 2003-03-19 | Celltech R&D Ltd | Biological products |
| ATE491953T1 (de) * | 2003-09-15 | 2011-01-15 | Oklahoma Med Res Found | Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis |
| DK2270045T3 (en) | 2004-02-06 | 2015-04-07 | Univ Massachusetts | ANTIBODIES AGAINST CLOSTRIDIUM DIFFICILE TOXINES AND APPLICATIONS THEREOF |
| EP2361933A3 (en) * | 2005-01-26 | 2012-05-02 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| JO3058B1 (ar) * | 2005-04-29 | 2017-03-15 | Applied Molecular Evolution Inc | الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها |
| HUE029021T2 (en) * | 2005-06-21 | 2017-02-28 | Xoma (Us) Llc | IL-1beta-binding antibodies and fragments thereof |
| PL1940465T3 (pl) * | 2005-10-26 | 2013-01-31 | Novartis Ag | Nowe zastosowanie przeciwciał anty-IL-1beta |
| HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-IL-23 antibodies, preparations, methods and applications |
| US7943328B1 (en) | 2006-03-03 | 2011-05-17 | Prometheus Laboratories Inc. | Method and system for assisting in diagnosing irritable bowel syndrome |
| KR20110079922A (ko) * | 2006-04-14 | 2011-07-11 | 노파르티스 아게 | 안과 장애 치료를 위한 ｉｌ－1 항체의 용도 |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| EP3124045A3 (en) | 2006-12-20 | 2017-05-03 | Xoma (Us) Llc | Treatment of il-1 beta related diseases |
| EP2114443A4 (en) * | 2006-12-29 | 2011-08-10 | Abbott Lab | IL-1A / IL-1B ANTIBODY WITH DOUBLE SPECIFICITY |
| CA2679400A1 (en) | 2007-02-28 | 2008-09-04 | Schering Corporation | Combination therapy for treatment of immune disorders |
| CN104873972A (zh) * | 2007-05-29 | 2015-09-02 | 诺华股份有限公司 | 抗IL-1β治疗的新适应症 |
| SI2391650T1 (sl) | 2007-12-20 | 2015-03-31 | Xoma (Us) Llc | Postopki za zdravljenje protina |
| CA2727171A1 (en) * | 2008-06-06 | 2009-12-10 | Xoma Technology Ltd. | Methods for the treatment of rheumatoid arthritis |
| JP2012502058A (ja) | 2008-09-05 | 2012-01-26 | ゾーマ テクノロジー リミテッド | β細胞機能の改善のための方法 |
| SI2493922T1 (sl) | 2009-10-26 | 2017-06-30 | F. Hoffmann-La Roche Ag | Postopek za proizvodnjo glikoziliranega imunoglobulina |
| BR112012028557A2 (pt) | 2010-05-07 | 2019-09-24 | Xoma Technology Ltd. | uso de um anticorpo anti-il-1b ou de fragmentos de ligação do mesmo. |
| DE102010033565B4 (de) * | 2010-07-27 | 2012-06-21 | Tetec Tissue Engineering Technologies Ag | Marker zur Bestimmung von Chondrozyten |
| SMT201700023T1 (it) | 2010-08-02 | 2017-03-08 | Regeneron Pharma | Topi che producono proteine leganti vl |
| CN103328511B (zh) | 2010-09-10 | 2016-01-20 | 埃派斯进有限公司 | 抗-IL-1β抗体及其使用方法 |
| ME02106B (me) * | 2011-02-25 | 2015-10-20 | Regeneron Pharma | Miševi sa adam6 |
| HUE047278T2 (hu) | 2011-08-05 | 2020-04-28 | Regeneron Pharma | Humanizált univerzális könnyûláncú egerek |
| DE102011083595A1 (de) | 2011-09-28 | 2013-03-28 | Bayer Pharma AG | Inhibition der Wirkung von Interleukin 1 beta zur Behandlung der Endometriose |
| WO2013096516A1 (en) | 2011-12-19 | 2013-06-27 | Xoma Technology Ltd. | Methods for treating acne |
| SG10201605675WA (en) | 2011-12-20 | 2016-09-29 | Regeneron Pharma | Humanized light chain mice |
| LT2814843T (lt) | 2012-02-13 | 2020-09-25 | Agency For Science, Technology And Research | ŽMOGAUS MONOKLONINIAI ANTIKŪNAI, NEUTRALIZUOJANTYS IL-1ß |
| ME03551B (me) | 2012-06-12 | 2020-07-20 | Regeneron Pharma | Humanizovane nehumane živoтinje sa ograničenim lokusima imunoglobulinskog тeškog lanca |
| AU2015231025A1 (en) | 2014-03-21 | 2016-09-15 | Regeneron Pharmaceuticals, Inc. | Vl antigen binding proteins exhibiting distinct binding characteristics |
| CA3124228C (en) | 2014-03-21 | 2024-05-14 | Regeneron Pharmaceuticals, Inc. | Non-human animals that make single domain binding proteins |
| CA2979702A1 (en) | 2015-03-19 | 2016-09-22 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
| MX2020009265A (es) | 2018-03-05 | 2020-10-01 | Janssen Biotech Inc | Metodos para tratar la enfermedad de crohn con un anticuerpo especifico anti-il23. |
| CN110818793A (zh) | 2018-08-14 | 2020-02-21 | 中山康方生物医药有限公司 | 抗IL-1β的抗体、其药物组合物及其用途 |
| IL283192B2 (en) | 2018-11-20 | 2025-10-01 | Janssen Biotech Inc | A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody |
| JP7805788B2 (ja) | 2019-05-23 | 2026-01-26 | ヤンセン バイオテツク，インコーポレーテツド | Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 |
| IL298389A (en) | 2020-05-21 | 2023-01-01 | Janssen Biotech Inc | Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha |
| CN116063489B (zh) * | 2022-10-21 | 2026-01-30 | 杭州靶向食品科技有限公司 | 一种治疗痛风的单克隆抗体及其相应的组合物 |
| CN121511262A (zh) | 2023-06-28 | 2026-02-10 | 北京哲源科技有限责任公司 | 靶向pd-l1和il-1的双特异性抗体及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4772685A (en) | 1985-10-02 | 1988-09-20 | Merck & Co., Inc. | Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies |
| US4935343A (en) * | 1986-08-08 | 1990-06-19 | Syntex (U.S.A.) Inc. | Monoclonal antibodies for interleukin-1β |
| FR2640146B1 (fr) * | 1988-12-08 | 1993-12-24 | Commissariat A Energie Atomique | Anticorps monoclonaux anti-interleukines 1(alpha) et 1(beta), leur procede de production et applications desdits anticorps a la detection des interleukines 1(alpha) et 1(beta) et en therapeutique |
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
| JP3714683B2 (ja) * | 1992-07-30 | 2005-11-09 | 生化学工業株式会社 | 抗リウマチ剤 |
| US5429614A (en) | 1993-06-30 | 1995-07-04 | Baxter International Inc. | Drug delivery system |
| WO1995001997A1 (en) * | 1993-07-09 | 1995-01-19 | Smithkline Beecham Corporation | RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN |
| US6051228A (en) | 1998-02-19 | 2000-04-18 | Bristol-Myers Squibb Co. | Antibodies against human CD40 |
| GB0001448D0 (en) * | 2000-01-21 | 2000-03-08 | Novartis Ag | Organic compounds |
-
2000
- 2000-01-21 GB GBGB0001448.0A patent/GB0001448D0/en not_active Ceased
-
2001
- 2001-01-18 CO CO01003434A patent/CO5261584A1/es active IP Right Grant
- 2001-01-18 MY MYPI20010226A patent/MY155269A/en unknown
- 2001-01-19 CN CN018039529A patent/CN1395581B/zh not_active Expired - Fee Related
- 2001-01-19 SK SK1035-2002A patent/SK288054B6/sk not_active IP Right Cessation
- 2001-01-19 MX MXPA02007091A patent/MXPA02007091A/es active IP Right Grant
- 2001-01-19 SI SI200130698T patent/SI1248804T2/sl unknown
- 2001-01-19 TR TR2002/01780T patent/TR200201780T2/xx unknown
- 2001-01-19 AR ARP010100247A patent/AR027253A1/es active IP Right Grant
- 2001-01-19 DK DK01905671.2T patent/DK1248804T4/da active
- 2001-01-19 DE DE60124863T patent/DE60124863T3/de not_active Expired - Lifetime
- 2001-01-19 WO PCT/EP2001/000591 patent/WO2001053353A2/en not_active Ceased
- 2001-01-19 CA CA2396212A patent/CA2396212C/en not_active Expired - Fee Related
- 2001-01-19 PL PL356297A patent/PL207642B1/pl unknown
- 2001-01-19 BR BR0107661-2A patent/BR0107661A/pt not_active IP Right Cessation
- 2001-01-19 NZ NZ519936A patent/NZ519936A/en not_active IP Right Cessation
- 2001-01-19 CZ CZ20022531A patent/CZ302738B6/cs not_active IP Right Cessation
- 2001-01-19 PE PE2001000065A patent/PE20011219A1/es not_active Application Discontinuation
- 2001-01-19 KR KR1020027009374A patent/KR100697126B1/ko not_active Expired - Fee Related
- 2001-01-19 HK HK03102022.5A patent/HK1050013A1/zh unknown
- 2001-01-19 JP JP2001553825A patent/JP3978338B2/ja not_active Expired - Fee Related
- 2001-01-19 HU HU0204156A patent/HUP0204156A3/hu not_active Application Discontinuation
- 2001-01-19 US US10/181,324 patent/US20030124617A1/en not_active Abandoned
- 2001-01-19 EP EP01905671A patent/EP1248804B2/en not_active Expired - Lifetime
- 2001-01-19 ES ES01905671T patent/ES2274865T5/es not_active Expired - Lifetime
- 2001-01-19 RU RU2002121649/13A patent/RU2264413C2/ru not_active IP Right Cessation
- 2001-01-19 AT AT01905671T patent/ATE346868T1/de active
- 2001-01-19 AU AU33697/01A patent/AU772949B2/en not_active Ceased
- 2001-01-19 PT PT01905671T patent/PT1248804E/pt unknown
- 2001-01-19 IL IL15055101A patent/IL150551A0/xx unknown
-
2002
- 2002-07-02 IL IL150551A patent/IL150551A/en not_active IP Right Cessation
- 2002-07-05 NO NO20023266A patent/NO329816B1/no not_active IP Right Cessation
- 2002-07-16 ZA ZA2002/05659A patent/ZA200205659B/en unknown
-
2006
- 2006-07-11 US US11/484,472 patent/US7491392B2/en not_active Expired - Fee Related
- 2006-12-29 CY CY20061101860T patent/CY1107989T1/el unknown
-
2007
- 2007-01-04 JP JP2007000148A patent/JP2007097598A/ja active Pending
-
2009
- 2009-01-09 US US12/351,007 patent/US20090232803A1/en not_active Abandoned
-
2011
- 2011-03-10 US US13/044,918 patent/US20110182894A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007097598A5 (https=) | ||
| RU2002121649A (ru) | Рекомбинантные антитела к человеческому интерлейкину 1β | |
| JP2018527919A5 (https=) | ||
| JP2010526028A5 (https=) | ||
| RU2003100512A (ru) | Антитела к человеческому мср-1 | |
| JP2013538057A5 (https=) | ||
| JP2015533795A5 (https=) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2022543387A5 (https=) | ||
| CA2420231A1 (en) | Antibodies to human il-1.beta. | |
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| JP2014526898A5 (https=) | ||
| JP2015522252A5 (https=) | ||
| JP2012504955A5 (https=) | ||
| JP2017052784A5 (https=) | ||
| JP2016511277A5 (https=) | ||
| RU2010120879A (ru) | Антитела против g-белка распираторно-синцитиального вируса (rsv) | |
| RU2016129113A (ru) | Антитела к pd-1 собак | |
| JP2011505867A5 (https=) | ||
| RU2012107286A (ru) | Высокоаффинные человеческие антитела к человеческому ангиопоэтину-2 | |
| JP2010511388A5 (https=) | ||
| HRP20170568T1 (hr) | Protutijela anti-ox40 i postupci za njihovu uporabu | |
| NZ597996A (en) | Antibodies against human respiratory syncytial virus (rsv) and methods of use | |
| JP2011528902A5 (https=) | ||
| JP2010528601A5 (https=) |